Home › Research › Health systems and care delivery
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Eric Jutkowitz, Julie Bynum, Susan L. Mitchell, Noelle M. Cocoros, Oren Shapira, Kevin Haynes, Vinit P. Nair, Cheryl N. McMahill‐Walraven et al.. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, 2020-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service.
What this study adds
Evidence grade: Low
This study found that the diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans was 5.6% in 2014 and 6.5% in 2016, lower than rates reported in Medicare fee-for-service. Reported effect size: 5.6%; 6.5%; 61.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jutkowitz, E., Bynum, J., Mitchell, S. L., Cocoros, N. M., Shapira, O., Haynes, K., et al. (2020). Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.12048
Vancouver
Jutkowitz E, Bynum J, Mitchell SL, Cocoros NM, Shapira O, Haynes K, et al. Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 2020. doi:10.1002/dad2.12048. PMID: 32647744.
BibTeX
@article{jutkowitz2020-32647744,
author = {Jutkowitz, Eric and Bynum, Julie and Mitchell, Susan L. and Cocoros, Noelle M. and Shapira, Oren and Haynes, Kevin and Nair, Vinit P. and McMahill‐Walraven, Cheryl N. and others},
title = {{Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans}},
journal = {Alzheimer s \& Dementia Diagnosis Assessment \& Disease Monitoring},
year = {2020},
doi = {10.1002/dad2.12048},
pmid = {32647744},
url = {https://doi.org/10.1002/dad2.12048}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively.
- In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities.
- By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan.
- The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts.
- The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service.
Why it matters
This study found that the diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans was 5.6% in 2014 and 6.5% in 2016, lower than rates reported in Medicare fee-for-service. By one year after the index date, 32% of beneficiaries with dementia had disenrolled from their plan.
Study details
- Effect size5.6%; 6.5%; 61.8%
- Evidence strengthLow
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring) |
| Journal's citation record | 1 / 4 | Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring: journal h-index 86 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 29 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.6 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 3 / 6 | Cited 3.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 16 other studies in this library |
| Still being cited | 1 / 4 | Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Ellen P. McCarthy: h-index 67 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32647744) |
| Free to read | 2 / 2 | Free to read |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/dad2.12048
- PubMed: 32647744
- Original source →
- Free full text: Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
15 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Health systems and care delivery from nearby years
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.